Free Trial

Supernus Pharmaceuticals (SUPN) SEC Filings & 10K Form

Supernus Pharmaceuticals logo
$36.12 +0.59 (+1.66%)
(As of 11/20/2024 ET)

Recent Supernus Pharmaceuticals SEC Filings

DateFilerForm TypeView
11/08/2024
4:00 PM
Khattar Jack A. (Reporting)
Supernus Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/08/2024
3:19 PM
GEMAYEL GEORGES (Reporting)
Supernus Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/08/2024
3:08 PM
Khattar Jack A. (Reporting)
Supernus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/08/2024
3:11 PM
GEMAYEL GEORGES (Reporting)
Supernus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/07/2024
3:59 PM
Khattar Jack A. (Reporting)
Supernus Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/07/2024
3:42 PM
GEMAYEL GEORGES (Reporting)
Supernus Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/04/2024
3:19 PM
Supernus Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/01/2024
3:35 PM
MACQUARIE GROUP LTD (Filed by)
Supernus Pharmaceuticals (Subject)
Form SC 13G/A
10/31/2024
10:55 AM
DIMENSIONAL FUND ADVISORS LP (Filed by)
Supernus Pharmaceuticals (Subject)
Form SC 13G
10/21/2024
3:48 PM
Supernus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/17/2024
3:16 PM
Supernus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/10/2024
4:03 PM
Supernus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/13/2024
3:30 PM
GEMAYEL GEORGES (Reporting)
Supernus Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/20/2024
4:00 PM
Bhatt Padmanabh P. (Reporting)
Supernus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2024
6:03 AM
Supernus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/06/2024
3:16 PM
Supernus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/06/2024
3:18 PM
Supernus Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/01/2024
3:19 PM
Martin Tami Tillotson (Reporting)
Supernus Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/31/2024
3:41 PM
Martin Tami Tillotson (Reporting)
Supernus Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/24/2024
3:48 PM
Martin Tami Tillotson (Reporting)
Supernus Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/23/2024
3:20 PM
Supernus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/22/2024
3:24 PM
Martin Tami Tillotson (Reporting)
Supernus Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/19/2024
3:28 PM
Martin Tami Tillotson (Reporting)
Supernus Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/16/2024
3:14 PM
Martin Tami Tillotson (Reporting)
Supernus Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/16/2024
3:18 PM
Martin Tami Tillotson (Reporting)
Supernus Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/15/2024
3:53 PM
Martin Tami Tillotson (Reporting)
Supernus Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/17/2024
4:15 PM
Supernus Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
05/09/2024
3:09 PM
Supernus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/24/2024
3:05 PM
Supernus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/24/2024
3:08 PM
Supernus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/08/2024
7:03 AM
Supernus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/25/2024
4:00 PM
Bhatt Padmanabh P. (Reporting)
Supernus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/22/2024
4:00 PM
Bhatt Padmanabh P. (Reporting)
Supernus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/21/2024
4:01 PM
Bhatt Padmanabh P. (Reporting)
Supernus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/15/2024
5:39 PM
Bhatt Padmanabh P. (Reporting)
Supernus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/14/2024
4:00 PM
Bhatt Padmanabh P. (Reporting)
Supernus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2024
3:23 PM
Bhatt Padmanabh P. (Reporting)
Supernus Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/29/2024
4:00 PM
Khattar Jack A. (Reporting)
Supernus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/29/2024
4:01 PM
Mottola Frank (Reporting)
Supernus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2024
4:28 PM
Khattar Jack A. (Reporting)
Supernus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
1:33 PM
ARMISTICE CAPITAL, LLC (Filed by)
Supernus Pharmaceuticals (Subject)
Form SC 13G/A
JD Vance Predicts: Wall Street vs. Trump & Your Money (Ad)

Trump's back in the White House, but Wall Street is pissed. Here's the deal: Wall Street's about to purposely crash the bond market to sabotage Trump's comeback.

Get your free guide NOW before it's too late.
02/14/2024
6:06 AM
MACQUARIE GROUP LTD (Filed by)
Supernus Pharmaceuticals (Subject)
Form SC 13G
02/05/2024
8:21 AM
Supernus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/19/2024
1:40 PM
BlackRock Inc. (Filed by)
Supernus Pharmaceuticals (Subject)
Form SC 13G/A
01/10/2024
3:08 PM
Martin Tami Tillotson (Reporting)
Supernus Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/26/2023
4:00 PM
Khattar Jack A. (Reporting)
Supernus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/26/2023
4:01 PM
Rubin Jonathan (Reporting)
Supernus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:SUPN) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners